In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks
In topline phase 3 results, retatrutide lowered A1C and body weight more than semaglutide 2 mg in adults with type ...
Tag: type 2 diabetes
Higher coffee intake is associated with lower visceral fat despite similar body mass index
1. A Finnish cohort study of 2,264 adults found that higher coffee intake was associated with lower total and visceral ...
A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes
1. Adherence to a healthy lifestyle is associated with an approximately 44% reduction in infection incidence among patients living with ...
Resistance training is associated with lower risk of type 2 diabetes
1. Resistance training among US adult health care professionals was associated with lower type 2 diabetes (T2D) risk, especially when ...
Biweekly glucagon-like peptide-1 receptor agonist bofanglutide improves glycemic control
1. In this randomized controlled trial, biweekly injections of the novel glucagon-like peptide-1 receptor agonist (GLP-1RA) bofanglutide resulted in greater ...
Food coloring additives are associated with higher incidence of type 2 diabetes
1. Several widely consumed natural and synthetic food coloring additives were associated with higher type 2 diabetes incidence. Evidence Rating ...
2 Minute Medicine Rewind June 8, 2026
Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort 1. Several widely consumed natural and ...
Metformin remains a leading candidate for pharmacologic longevity intervention
Metformin remains a leading candidate for pharmacologic longevity intervention Metformin continues to occupy a unique position in longevity medicine because ...
Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial
1. Retatrutide met all major Phase 3 endpoints, delivering substantial reductions in both A1C and body weight in patients with ...
Tirzepatide improves patient well-being compared with dulaglutide in type 2 diabetes
1. In this randomized controlled trial, switching from dulaglutide to tirzepatide was associated with greater improvements in patient-reported quality of ...
Get the app